Cadila Pharmaceuticals

Government officials from Himachal Pradesh, Gujarat and Andhra Pradesh showcase opportunities and incentives for investors

Cadila plans to launch multiple biosimilar products this year for the Indian market

It will be marketed under brand name Esiloc in India for treatment of hyperacidity and drug induced gastritis

The Phase III study is expected to involve 270 patients and will be conducted in India on patients with various skin types

Kaka-Ba hospital, a CSR initiative of Cadila Pharmaceuticals located in Hansot, has been working towards building awareness in the…

CSIR announced that it will initiate a randomised, blinded, two arms, active comparator-controlled clinical trial to evaluate the…

With roughly only one women out of ten professionals constituting the workforce of the Indian pharma industry, it seems that it…

Pharma experts share their views and insights on the impact and implications of Budget 2020

More than 1,000 saplings were planted in the campus in the presence of over 300 guests to mark the occasion

This award was conferred on the Learning and Development (L&D) team of Cadila Pharma for their initiative of training the…